352 related articles for article (PubMed ID: 27617576)
21. Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.
Wang Y; Sheng Q; Spillman MA; Behbakht K; Gu H
Oncogene; 2012 May; 31(20):2512-20. PubMed ID: 21996746
[TBL] [Abstract][Full Text] [Related]
22. RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3.
Zhou K; Rao J; Zhou ZH; Yao XH; Wu F; Yang J; Yang L; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
Lab Invest; 2018 Aug; 98(8):989-998. PubMed ID: 29884911
[TBL] [Abstract][Full Text] [Related]
23. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.
Ha JH; Ward JD; Radhakrishnan R; Jayaraman M; Song YS; Dhanasekaran DN
Oncotarget; 2016 Jun; 7(25):37664-37679. PubMed ID: 27166196
[TBL] [Abstract][Full Text] [Related]
24. Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells.
Chen D; Wang J; Zhang Y; Chen J; Yang C; Cao W; Zhang H; Liu Y; Dou J
Int J Gynecol Cancer; 2013 Oct; 23(8):1357-66. PubMed ID: 24257549
[TBL] [Abstract][Full Text] [Related]
25. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
[TBL] [Abstract][Full Text] [Related]
26. Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition.
Huang YT; Hsu YT; Wu PY; Yeh YM; Lin PC; Hsu KF; Shen MR
J Exp Clin Cancer Res; 2024 Mar; 43(1):65. PubMed ID: 38424547
[TBL] [Abstract][Full Text] [Related]
27. Rac1-mediated cytoskeleton rearrangements induced by intersectin-1s deficiency promotes lung cancer cell proliferation, migration and metastasis.
Jeganathan N; Predescu D; Zhang J; Sha F; Bardita C; Patel M; Wood S; Borgia JA; Balk RA; Predescu S
Mol Cancer; 2016 Sep; 15(1):59. PubMed ID: 27629044
[TBL] [Abstract][Full Text] [Related]
28. Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells.
Lam CR; Tan C; Teo Z; Tay CY; Phua T; Wu YL; Cai PQ; Tan LP; Chen X; Zhu P; Tan NS
Cell Death Dis; 2013 Oct; 4(10):e848. PubMed ID: 24113182
[TBL] [Abstract][Full Text] [Related]
29. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
[TBL] [Abstract][Full Text] [Related]
30. ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation.
Shin S; Buel GR; Nagiec MJ; Han MJ; Roux PP; Blenis J; Yoon SO
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2967-2976. PubMed ID: 30728292
[TBL] [Abstract][Full Text] [Related]
31. Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
Gupta N; Xu Z; El-Sehemy A; Steed H; Fu Y
Gynecol Oncol; 2013 Jul; 130(1):200-6. PubMed ID: 23542683
[TBL] [Abstract][Full Text] [Related]
32. Laminin-induced activation of Rac1 and JNKp46 is initiated by Src family kinases and mimics the effects of skeletal muscle contraction.
Zhou Y; Jiang D; Thomason DB; Jarrett HW
Biochemistry; 2007 Dec; 46(51):14907-16. PubMed ID: 18044967
[TBL] [Abstract][Full Text] [Related]
33. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
[TBL] [Abstract][Full Text] [Related]
34. TFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transition.
Dimitrova Y; Gruber AJ; Mittal N; Ghosh S; Dimitriades B; Mathow D; Grandy WA; Christofori G; Zavolan M
Biol Direct; 2017 Apr; 12(1):8. PubMed ID: 28412966
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
36. DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer.
Matsunuma R; Chan DW; Kim BJ; Singh P; Han A; Saltzman AB; Cheng C; Lei JT; Wang J; Roberto da Silva L; Sahin E; Leng M; Fan C; Perou CM; Malovannaya A; Ellis MJ
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11978-E11987. PubMed ID: 30498031
[TBL] [Abstract][Full Text] [Related]
37. The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.
Ungewiss C; Rizvi ZH; Roybal JD; Peng DH; Gold KA; Shin DH; Creighton CJ; Gibbons DL
Sci Rep; 2016 Jan; 6():18652. PubMed ID: 26728244
[TBL] [Abstract][Full Text] [Related]
38. Sos-mediated activation of rac1 by p66shc.
Khanday FA; Santhanam L; Kasuno K; Yamamori T; Naqvi A; Dericco J; Bugayenko A; Mattagajasingh I; Disanza A; Scita G; Irani K
J Cell Biol; 2006 Mar; 172(6):817-22. PubMed ID: 16520382
[TBL] [Abstract][Full Text] [Related]
39. Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1/Cdc42-PAK signalling pathway.
Liu C; Zhang L; Cui W; Du J; Li Z; Pang Y; Liu Q; Shang H; Meng L; Li W; Song L; Wang P; Xie Y; Wang Y; Liu Y; Hu J; Zhang W; Li F
EBioMedicine; 2019 Dec; 50():122-134. PubMed ID: 31761617
[TBL] [Abstract][Full Text] [Related]
40. Targeting epithelial to mesenchymal transition in prostate cancer by a novel compound, plectranthoic acid, isolated from Ficus microcarpa.
Akhtar N; Syed DN; Lall RK; Mirza B; Mukhtar H
Mol Carcinog; 2018 May; 57(5):653-663. PubMed ID: 29436741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
